Fig. 1From: SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomasExpression of SLC39A1 in normal and glioma tissues. SLC39A1 expression in normal and glioma tissues from a TCGA datasets (n = 705) , b GSE16011 datasets (n = 284), c GSE44971 datasets (n = 58), d GSE11260 datasets (n = 70). TCGA, The Cancer Genome Atlas. ***P < 0.001 indicates a significant differenceBack to article page